Metastatic, malignant phyllodes tumor (PT) of the breast is a rare and aggressive neoplasm. Currently, there is no agreed upon consensus as to best management practices. A systematic review of literature was conducted investigating surgical, chemotherapeutic, and radiotherapeutic management for metastatic PT. Databases employed to identify articles included Embase, PubMed, and SAGE Journals. Diagnosis of metastatic PT has been of significant difficulty to radiologists as it is often confused with fibroadenomas. Surgically, metastatectomy has been correlated with increased overall survival (of 25.9 versus 9.9 months; P = .01). Radiotherapy has often been associated with palliation and pain control in metastatic, malignant neoplasia. However, one study showed that in malignant PT, radiation was associated with significantly lower rates of local recurrence (OR: 0.048 versus 0.209). Anthracycline containing chemotherapy regimens has been associated with improved overall survival (22.4 months versus 13.2 months; P = .040). Further research must be conducted into this rare malignancy to elucidate accurate diagnosis and care for patients with advanced metastatic or malignant phyllodes tumors.
LimaiemFKashyapS, Phyllodes tumor of the breast. In: StatPearls. Treasure Island (FL): Petersburg, FL: StatPearls Publishing2022.
2.
KudelaEKajoKKozubikE, et al.Recurrent giant malignant phyllodes tumor of the breast. Case Rep Obstet Gynecol. 2021;2021:2476691. doi:10.1155/2021/2476691
3.
BediDClarkBZCarterGJ, et al.Prognostic significance of three-tiered world health organization classification of phyllodes tumor and correlation to singapore general hospital nomogram. Am J Clin Pathol. 2022;158(3):362-371. doi:10.1093/ajcp/aqac055
4.
WangHWangXWangCF. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast. Asian Pac J Cancer Prev. 2014;15(24):5-107915. doi:10.7314/apjcp.2014.15.24.10791
5.
LissidiniGMulèASantoroA, et al.Malignant phyllodes tumor of the breast: a systematic review. Pathologica. 2022;114(2):111-120. doi:10.32074/1591-951X-754
6.
DitsathamCChongruksutW. Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience. Cancer Manag Res. 2019;11:7805-7811. doi:10.2147/CMAR.S215039
7.
RobertsNRunkDM. Aggressive malignant phyllodes tumor. Int J Surg Case Rep. 2015;8C:5-161. doi:10.1016/j.ijscr.2014.12.041
8.
FedeABSPereira SouzaRDoiM, et al.Malignant phyllodes tumor of the breast: a practice review. Clin Pract. 2021;11(2):205-215. doi:10.3390/clinpract11020030
9.
RayzahM. Phyllodes tumors of the breast: a literature review. Cureus. 2020;12(9):e10288. doi:10.7759/cureus.10288
10.
ZhangYKleerCG. Phyllodes tumor of the breast: histopathologic features, differential diagnosis, and molecular/genetic updates. Arch Pathol Lab Med. 2016;140(7):71-665. doi:10.5858/arpa.2016-0042-RA
11.
TanPHThikeAATanWJ, et al.Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69-76. doi:10.1136/jclinpath-2011-200368
12.
LimRSCordeiroELauJLimARobertsASeelyJ. Phyllodes tumors-the predictors and detection of recurrence. Can Assoc Radiol J. 2021;72(2):251-257. doi:10.1177/0846537119899553
13.
RamakantPSelvamaniThereseMMPaulMJ. Metastatic malignant phyllodes tumor of the breast: an aggressive disease-analysis of 7 cases. Indian J Surg Oncol. 2015;6(4):9-363. doi:10.1007/s13193-015-0397-9
14.
WiratkapunCPiyapanPLertsithichaiPLarbcharoensubN. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol. 2014;20(1):27-33.
15.
LeeJSChangJHagemannISBennettDL. Malignant phyllodes tumor: imaging features with histopathologic correlation. Journal of Breast Imaging. 2021;3(6):703-711.
16.
KawashimaHMiyatiTOhnoN, et al.Differentiation between phyllodes tumours and fibroadenomas using intravoxel incoherent motion magnetic resonance imaging: comparison with conventional diffusion-weighted imaging. Br J Radiol. 2018;91(1084):20170687.
17.
WardSTJewkesAJJonesBG, et al.The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumours of the breast. Int J Surg. 2012;10(9):31-527.
18.
DumanLGezerNSBalcıP, et al.Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care (Basel). 2016;11(2):7-123.
19.
BogachJShakeelSWrightFCHongNJL. Phyllodes tumors: a scoping review of the literature. Ann Surg Oncol. 2022;29(1):446-459.
20.
KalamboMAdradaBEAdeyefaMM, et al.Phyllodes tumor of the breast: ultrasound-pathology correlation. AJR Am J Roentgenol. 2018;210(4):W173-W179.
21.
MaoYXiongZWuS, et al.The predictive value of magnetic resonance imaging-based texture analysis in evaluating histopathological grades of breast phyllodes tumor. J Breast Cancer. 2022;25(2):117-130.
22.
BalajiRRamachandranKN. Magnetic resonance imaging of a benign phyllodes tumor of the breast. Breast Care (Basel). 2009;4(3):189-191. doi:10.1159/000220604
23.
AlhabshiSMRahmatKAbu HassanHWesterhoutCJChandranPA. Advanced MRI applications and findings of malignant phyllodes tumour: review of two cases. Jpn J Radiol. 2013;31(5):8-342.
24.
MaiHMaoYDongT, et al.The utility of texture analysis based on breast magnetic resonance imaging in differentiating phyllodes tumors from fibroadenomas. Front Oncol. 2019;9:1021
25.
YabuuchiHSoedaHMatsuoY, et al.Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology. 2006;241(3):9-702.
26.
LiXGuoHCongC, et al.The potential value of texture analysis based on dynamic contrast-enhanced mr images in the grading of breast phyllode tumors. Front. Oncol. 2021;11:745242.
27.
MaWGuoXLiuL, et al.Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors. Am J Transl Res. 2020;12(5):2083-2092.
28.
RuanZQuanQWangQJiangJPengR. New staging system and prognostic model for malignant phyllodes tumor patients without distant metastasis: a development and validation study. J Clin Med. 2023;12(5):1889
29.
AdesoyeTNeumanHBWilkeLGSchumacherJRSteimanJGreenbergCC. Current trends in the management of phyllodes tumors of the breast. Ann Surg Oncol. 2016;23(10):205-3199.
30.
LiGZRautCPHuntKKFengMChughR. Breast sarcomas, phyllodes tumors, and desmoid tumors: epidemiology, diagnosis, staging, and histology-specific management considerations. Am Soc Clin Oncol Educ Book. 2021;41:390-404.
31.
AminMBGreeneFLEdgeSB, et al.The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-99.
32.
NeronMSajousCThezenasS, et al.Impact of metastasis surgery and alkylating-agent-based chemotherapy on outcomes of metastatic malignant phyllodes tumors: a multicenter retrospective study. Ann Surg Oncol. 2020;27(5):1693-1699. doi:10.1245/s10434-019-08097-x
33.
TelliMLHorstKCGuardinoAEDirbasFMCarlsonRW. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007;5(3):30-324. doi:10.6004/jnccn.2007.0027
34.
National Comprehensive Cancer Network. Phyllodes Tumor: National Comprehensive Cancer Network out of Plymouth Meeting; PA2016.
35.
MacdonaldOKLeeCMTwardJDChappelCDGaffneyDK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the surveillance, epidemiology, and end results (SEER) program. Cancer. 2006;107:33-2127.
36.
LuYChenYZhuL, et al.Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis. Ann Surg Oncol. 2019;26(5):1263-1275. doi:10.1245/s10434-018-07134-5
37.
ChunLPo-ShengYChangYCWen-ChingKHung-BunLWuPS. Clinical features, prognostic factors, and treatment outcomes in 611 patients with phyllodes tumors of the breast: the experience of a single institution in Taiwan. Journal of Cancer Research and Practice. 2022;9(1):11-21.
38.
ZhouZRWangCCYangZZYuXLGuoXM. Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis. 2016;8(11):3361-3368.
39.
PapasYAsmarAEGhandourFHajjI. Malignant phyllodes tumors of the breast: a comprehensive literature review. Breast J. 2020;26:240-244.
40.
YuCYHuangTWTamKW. Management of phyllodes tumor: a systematic review and meta-analysis of real-world evidence. Int J Surg. 2022;107:106969. doi:10.1016/j.ijsu.2022.106969
41.
ParkerSJHarriesSA. Phyllodes tumours. Postgrad Med J. 2001;77(909):35-428.
42.
AsogluOUgurluMMBlanchardK, et al.Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:7-1011.
43.
BelkacémiYBousquetGMarsigliaH, et al.Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008;70(2):492-500. doi:10.1016/j.ijrobp.2007.06.059
ZhaoWTianQZhaoA, et al.The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis. Breast Cancer. 2021;28(1):110-118.
46.
KimYJKimK. Radiation therapy for malignant phyllodes tumor of the breast: an analysis of SEER data. Breast. 2017;32:26-32doi:10.1016/j.breast.2016.12.006
47.
ZengSZhangXYangDWangXRenG. Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: a systematic review and meta-analysis. Mol Clin Oncol. 2015;3(3):663-671.
48.
KimSKimJYKimDHJungWHKooJS. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat. 2013;141:63-353.
49.
GnerlichJLWilliamsRTYaoKJaskowiakNKulkarniSA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009. Ann Surg Oncol. 2014;21(4):30-12222.
50.
ParkesAWangWLPatelS, et al.Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat. 2021;186(3):871-882. doi:10.1007/s10549-021-06116-8
51.
MituśJWBlecharzPWalasekTReinfussMJakubowiczJKulpaJ. Treatment of patients with distant metastases from phyllodes tumor of the breast. World J Surg. 2016;40(2):8-328. doi:10.1007/s00268-015-3262-7
52.
SuCCChenCJKuoSJ. Effect of Lipodox in combination with bevacizumab in a patient with a metastatic malignant phyllodes breast tumor: a case report. Oncol Lett. 2017;14(6):6685-6689. doi:10.3892/ol.2017.7094
53.
KoukourakisIMZygogianniAKoulouliasVKoukourakisMI. Successful treatment of a locally recurrent and metastatic malignant phyllodes tumor with accelerated radiotherapy and nab-paclitaxel, cisplatin, and liposomal doxorubicin chemotherapy. Chemotherapy. 2021;66(3):82-86. doi:10.1159/000517246
54.
WangXXieLHuWYanJQianXZhuL. Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report. BMC Womens Health. 2021;21(1):218. doi:10.1186/s12905-021-01359-5
